Clinical Trial

An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules

Name: An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules — clinical trial record (NCT07185035)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

A single-center, open-label dose-escalation design to evaluate the safety and efficacy of KN5001 in patients with pulmonary nodules.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-15.

Trial Details

NCT Number	NCT07185035
Lead Sponsor	The First Affiliated Hospital with Nanjing Medical University Collaborators: Rui Therapeutics Co., Ltd
Conditions	Pulmonary Nodules, Solitary, Pulmonary Nodules, Multiple
Enrollment	24 participants
Start Date	2025-09-20
Primary Completion	2026-09-20 (estimated)
Study Completion	2027-09-20 (estimated)
Updated on ClinicalTrials.gov	2025-12-01